Nagano K, Nakamura K, Urakami K I, Umeyama K, Uchiyama H, Koiwai K, Hattori S, Yamamoto T, Matsuda I, Endo F
Department of Pediatrics, Kumamoto University School of Medicine, Honjo, Japan.
Hepatology. 1998 Mar;27(3):799-807. doi: 10.1002/hep.510270323.
In patients with Wilson's disease, both copper incorporation into ceruloplasmin and excretion of this metal into bile are impaired. These conditions are caused by a genetic defect in the Wilson's disease gene (ATP7B). To investigate the Wilson's disease gene protein (ATPase7B) in hepatocytes, we constructed an expression plasmid carrying full-length complementary DNA for human Wilson's disease gene and attempted to express the gene in hepatocytes of LEC rats, an animal model of Wilson's disease. Transfection of hepatocytes, either in vitro or in vivo, was done using a newly developed cationic liposome containing 1,4-bis(3-(N-hexadecyl) aminopropyl) piperazine. Immunological analyses of human ATPase7B with specific monoclonal antibodies showed human ATPase7B to be a membrane protein with a molecular mass of 155 kd. Analysis of human ATPase7B expressed in hepatocytes from LEC rats suggested that this protein is present in the trans-Golgi network and at the plasma membrane, a distribution pattern similar to that of Menkes' disease protein (ATPase7A). These findings suggest that these two putative copper-transporting P-type ATPases function similarly at the cellular level. Cotransfection and coexpression of the human Wilson's disease gene and ceruloplasmin gene in cultured hepatocytes indicate that the distribution of ceruloplasmin is always accompanied by ATPase7B at the perinuclear region, but that part of ATPase7B localizes irrespective of the distribution of ceruloplasmin. Based on these investigations, we propose that ATPase7B exists in the trans-Golgi network and transports copper into this compartment. This seems to ensure an appropriate delivery of copper to the apoceruloplasmin. On the other hand, part of ATPase7B that is not accompanied by ceruloplasmin in the perinuclear region and at the plasma membrane seems to contribute to efflux of this metal from the hepatocytes. Thus the distribution patterns of ATPase7B in hepatocytes may explain the dual roles of this P-type ATPase in hepatocytes.
在威尔逊病患者中,铜掺入铜蓝蛋白以及该金属向胆汁中的排泄均受损。这些情况是由威尔逊病基因(ATP7B)的遗传缺陷引起的。为了研究肝细胞中的威尔逊病基因蛋白(ATP酶7B),我们构建了一个携带人威尔逊病基因全长互补DNA的表达质粒,并试图在威尔逊病动物模型LEC大鼠的肝细胞中表达该基因。使用新开发的含有1,4 - 双(3 - (N - 十六烷基)氨丙基)哌嗪的阳离子脂质体,在体外或体内对肝细胞进行转染。用特异性单克隆抗体对人ATP酶7B进行免疫分析表明,人ATP酶7B是一种分子量为155kd的膜蛋白。对LEC大鼠肝细胞中表达的人ATP酶7B的分析表明,该蛋白存在于反式高尔基体网络和质膜中,其分布模式与门克斯病蛋白(ATP酶7A)相似。这些发现表明,这两种假定的铜转运P型ATP酶在细胞水平上功能相似。在培养的肝细胞中对人威尔逊病基因和铜蓝蛋白基因进行共转染和共表达表明,铜蓝蛋白的分布在核周区域总是与ATP酶7B相伴,但部分ATP酶7B的定位与铜蓝蛋白的分布无关。基于这些研究,我们提出ATP酶7B存在于反式高尔基体网络中,并将铜转运到这个区室。这似乎确保了铜向脱辅基铜蓝蛋白的适当递送。另一方面,在核周区域和质膜中未与铜蓝蛋白相伴的部分ATP酶7B似乎有助于这种金属从肝细胞中流出。因此,ATP酶7B在肝细胞中的分布模式可能解释了这种P型ATP酶在肝细胞中的双重作用。